Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,208 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCATGet Free Report) COO Daniel Lesueur sold 5,208 shares of the company’s stock in a transaction dated Wednesday, July 3rd. The shares were sold at an average price of $6.15, for a total transaction of $32,029.20. Following the transaction, the chief operating officer now owns 155,215 shares in the company, valued at approximately $954,572.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Health Catalyst Trading Down 4.6 %

NASDAQ HCAT opened at $5.86 on Thursday. Health Catalyst, Inc. has a 12 month low of $5.45 and a 12 month high of $14.37. The stock has a market cap of $345.95 million, a price-to-earnings ratio of -3.17 and a beta of 1.32. The company’s 50 day moving average is $6.49 and its two-hundred day moving average is $7.75.

Health Catalyst (NASDAQ:HCATGet Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.05. The company had revenue of $74.72 million for the quarter, compared to analysts’ expectations of $74.81 million. Health Catalyst had a negative net margin of 35.56% and a negative return on equity of 11.86%. Sell-side analysts forecast that Health Catalyst, Inc. will post -0.4 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on HCAT. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price objective on shares of Health Catalyst in a research note on Tuesday, May 21st. Piper Sandler lowered their price objective on shares of Health Catalyst from $15.00 to $14.00 and set an “overweight” rating on the stock in a research note on Thursday, June 6th. Evercore ISI lowered their price objective on shares of Health Catalyst from $9.00 to $8.00 and set an “outperform” rating on the stock in a research note on Tuesday. Wells Fargo & Company lowered their price objective on shares of Health Catalyst from $14.00 to $13.00 and set an “overweight” rating on the stock in a research note on Friday, May 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $16.00 price objective on shares of Health Catalyst in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $11.91.

View Our Latest Report on Health Catalyst

Institutional Investors Weigh In On Health Catalyst

Institutional investors and hedge funds have recently modified their holdings of the stock. EntryPoint Capital LLC bought a new stake in shares of Health Catalyst during the first quarter valued at approximately $98,000. Los Angeles Capital Management LLC bought a new stake in shares of Health Catalyst during the fourth quarter valued at approximately $108,000. Tower Research Capital LLC TRC raised its position in shares of Health Catalyst by 285.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 12,018 shares of the company’s stock valued at $111,000 after buying an additional 8,900 shares during the last quarter. Virtus Investment Advisers Inc. bought a new stake in shares of Health Catalyst during the first quarter valued at approximately $115,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Health Catalyst by 23.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,072 shares of the company’s stock valued at $140,000 after buying an additional 2,817 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

(Get Free Report)

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

Read More

Insider Buying and Selling by Quarter for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.